Remove 2013 Remove Healthcare Remove Leads
article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

The Inflation Reduction Act’s health insurance subsidies and drug pricing reforms will improve health care affordability for Americans but won’t do a damn thing for our overall healthcare costs, which will keep rising. This is going to lead to a lot of health problems and associated costs. One in 4 U.S. percent of U.S.

article thumbnail

Should doctors refuse to treat obese patients?

World of DTC Marketing

This is leading to excessive costs to out healthcare system and something needs to be done. Obese patients cost all of us more money in healthcare costs, yet our healthcare system ignored this problem. Physicians don’t have the time to really talk to patients about their weight and lack of exercise.

Doctors 250
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

household income from 2009 to 2013 was $53,046, according to the United States Census Bureau, but many of the most recently approved anticancer treatments approved by the United States Food and Drug Administration (FDA) are priced well above $100,000 per year. .” This leads to a question; “where does it end?”

Pharma 210
article thumbnail

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Medgadget

AI is increasingly being used in healthcare to reduce clinician workloads and improve patient outcomes. AI-powered tools can also help identify patterns in medical data that can lead to faster diagnoses and better patient outcomes. Tell us about yourself – your background and how you got to where you are today at GE Healthcare.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

article thumbnail

Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals

pharmaphorum

Angela is working to ensure the UK life sciences sector expands its footprint as a priority country for inward investment in research and medicines launch as healthcare ecosystems recover from the impact of COVID-19. Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England.

Medicine 122
article thumbnail

Developments In B2B Healthcare Marketing

Scott’s Directories

The healthcare industry is pretty competitive, recording massive growth yearly. The spending in the healthcare industry increases by millions of dollars every year. Based on this, some B2B healthcare marketers may find it challenging to get the traction they need.